ArticleMolecular and cellular biochemistry2023

In-vitro inhibition of NLRP3 inflammasome by 3,6-dihydroxyflavone (3,6-DHF): a therapeutic strategy for the treatment of chronic inflammatory and autoimmune diseases.

Farheen Mansoor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.